Pazopanib hydrochloride
| Price | Get Latest Price | |||
| Package | 1g | 1KG | 10g | 100g |
| Min. Order: | 1g |
| Supply Ability: | 100kg/month |
| Update Time: | 2020-07-22 |
Product Details
| Product Name: Pazopanib hydrochloride | CAS No.: 635702-64-6 |
| Min. Order: 1g | Purity: 99% |
| Supply Ability: 100kg/month | Release date: 2020/07/22 |
▼
▲
Prodcut name
Pazopanib hydrochloride
MOQ
1G
CAS No.
635702-64-6
Appearance
White or off-white powder
Molecular Formula
C21H23N7O2S.HCl
Molecular Weight
473.98
Assay
≥99.0%
Application
Pharma grade or research purpose
Packing
As per your request
Storage
Preserve in tight,light-resistant containers in a cool place
Remarks
NA
Custom synthesis
Available
Supply Ability
100kg/month
Company Profile Introduction
Beijing Yibai Biotechnology Co., Ltd features:
1. Management layer's full experience in factory and skilled technicians followers;
2. 10 years experienced exporting sales team;
3. Independent R&D lab;
4. Two signed long term GMP partnership;
5. Rich resources of plenty idle factories for customized project;
6. High Efficiency working team with consistent path.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $48.00/10mg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-11-18 | |
| $0.00/1g |
VIP1Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2024-07-24 | |
| $0.00/1kg |
Nanjing Fred Technology Co., Ltd
|
2023-12-19 | ||
| $80.00/1KG |
Weijer International Trade (Hebei) Co., Ltd
|
2023-03-16 | ||
| $0.00/10g |
VIP3Y
|
Yangzhou Qinyuan Pharmatech Co.,ltd
|
2022-06-24 | |
| $0.00/25KG |
Hangzhou Huarong Pharm Co., Ltd.
|
2021-09-14 | ||
| $15.00/1KG |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-10 | ||
| $200.00/1g |
Baoji Guokang Healthchem co.,ltd
|
2021-06-07 | ||
| $1.00/1KG |
VIP7Y
|
Career Henan Chemical Co
|
2018-08-16 | |
| $15.00/1KG |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-09 |
China- Since: 2018-03-06
- Address: A2011, No.86, Wanxing Road, Changyang, Fangshan District, Beijing, China
INQUIRY